Novel Concepts of Glioblastoma Therapy Concerning Its Heterogeneity

Area of Science:

• Neuro-oncology
• Molecular Biology
• Genetics

Background:

• Glioblastoma, a malignant central nervous system tumor, has limited survival improvements despite decades of research.
• Advances in molecular biology and genetics have revealed glioblastoma's complexity, including tumor heterogeneity, which contributes to therapy resistance.
• Current anti-proliferative therapies are often ineffective due to dynamic heterogeneity and the emergence of resistant subclones.

Purpose of the Study:

• To explore novel diagnostic and therapeutic strategies for glioblastoma.
• To investigate the potential of liquid biopsy for real-time tumor profiling.
• To evaluate the diagnostic, predictive, and prognostic value of the tumor invasion spectrum.

Main Methods:

• Analysis of molecular markers for glioblastoma classification.
• Utilizing liquid biopsy for dynamic genetic change monitoring.
• Characterizing the tumor invasion spectrum through extracellular matrix component expression levels.

Main Results:

• Tumor heterogeneity presents a significant challenge to current glioblastoma treatments.
• Liquid biopsy offers a promising approach for real-time tumor assessment.
• The invasion spectrum provides valuable information for distinguishing subtypes, grades, and prognostic groups.

Conclusions:

• The invasion spectrum is a novel tool for classifying glioblastoma and predicting outcomes.
• Personalized oncotherapy strategies can be developed by integrating liquid biopsy and invasion spectrum analysis.
• These advancements represent crucial steps towards more effective glioblastoma treatments.